We recently compiled a list of the 14 Best Large Cap Dividend Growth Stocks To Buy Now. In this article, we are going to take ...

Eli Lilly and Company (NYSE: LLY) is one of two pharmaceutical stocks behind the weight loss drug craze that has impacted the ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on UnitedHealth (UNH – Research Report) and Eli ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

This is all despite a record-high share price of close to $973 achieved in 2024 on the momentum of tirzepatide sales. Investors may naturally be wondering what is going on with Eli Lilly and what ...

Citi analyst Geoff Meacham maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed last Friday at $785.41. Meacham covers the Healthcare sector ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

Mark Cuban Says If You Want To Get Rich, 'Throw A Hail Mary' And Invest 10% Of Savings In Bitcoin, But You Must Pretend You Already Lost It Charlie Munger Praised Buffett's $20 Billion 'No-Brainer ...

Eli Lilly's Q4 FY24 guidance adjustment is due to ... was achieved in the face of higher manufacturing costs, the loss of high-margin olanzapine portfolio revenue and ongoing investments in ...

In this article, we are going to take a look at where Eli Lilly And Co. (NYSE ... splitting stocks if their share prices are growing too high. On January 16, Mark Newton, Fundstrat Global head ...

Shares of Eli Lilly & Co. were headed for their worst day in nearly four years on Tuesday after the drugmaker provided a fourth-quarter revenue outlook that was below expectations, citing slower ...